Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Meredith was a major U.S. media and marketing company with significant operations in custom healthcare communications. Through acquisitions like Big Communications and partnerships with point-of-care networks such as Mesmerize, it provided tailored content solutions for pharmaceutical companies at the point of care and through consumer-facing brands like Health. Its offerings included print/digital campaigns targeting both B2B clients in pharma/biotech/insurance sectors and consumers seeking trusted health information. In late 2021, the company was acquired by IAC’s Dotdash group.[1][2][3][7]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Meredith.